Cronos Group recently expanded its share repurchase program after the Toronto Stock Exchange approved its notice, allowing the company to buy back up to US$50,000,000 of common shares on both U.S. and ...

TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) (TSX: CRON), an innovative global cannabis company, announced today that it has filed with the ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

The Canadian market has faced challenges recently, with first-quarter data indicating a technical recession amid ongoing inflation pressures. Despite these hurdles, the concept of penny stocks remains ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

Shares of Cronos Group Inc. CRON rallied 1.50% to $2.71 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.91% to ...

Cronos Group Inc (NASDAQ:CRON) shares are trading lower by 2.78% to $2.63 during Tuesday’s session. Shares of cannabis stocks are trading lower in sympathy with Tilray, which fell after reporting ...

Investors are clamoring to invest in publicly-traded cannabis companies as the legal marijuana market expands. Despite the clear growth potential in this industry, investors still need to exercise ...

Cronos Group Inc (NASDAQ:CRON) reported first-quarter financial results ahead of the market open Thursday. Here’s a look at the key highlights from the cannabis company’s report. Q1 Revenue: Cronos ...

TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 first quarter business results. "2025 is shaping up to be a ...

TORONTO, March 16, 2026 (GLOBE NEWSWIRE)-- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...